Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,318.00
Bid: 1,315.00
Ask: 1,319.00
Change: 43.00 (3.37%)
Spread: 4.00 (0.304%)
Open: 1,289.00
High: 1,318.00
Low: 1,267.00
Prev. Close: 1,275.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 tops 8,000; Centrica is star performer

Thu, 16th Feb 2023 08:49

(Alliance News) - Stock prices in London opened higher on Thursday, with London's blue-chip index pushing past the 8,000 mark once again, a day after it first broke the barrier.

The FTSE 100 index was up 26.04 points, 0.3%, at 8,023.87. It hit a new record high of 8,046.00 points earlier in the morning.

The FTSE 250 was up 50.25 points, 0.3%, at 20,222.84, and the AIM All-Share was up 0.62 of a point, or 0.1%, at 870.15.

The Cboe UK 100 was up 0.3% at 803.05, the Cboe UK 250 flat at 17,564.68, and the Cboe Small Companies up 0.3% at 14,059.05.

The pound was stronger on Thursday morning, though still bruised by UK inflation data on Wednesday that offered the Bank of England room to slow or stop UK interest rate hikes.

Inflation in the UK slowed by slightly more than forecast in January, though remained in double digits, figures from the Office for National Statistics showed. On an annual basis, the consumer price index eased to 10.1% in January from 10.5% in December. Consensus had expected inflation to cool to 10.3%, according to FXStreet.

The pound was quoted at USD1.2053 at early on Thursday in London, higher compared to USD1.2007 at the equities close on Wednesday.

Centrica was the best performing stock in the FTSE 100, up 4.0%.

The British Gas-owner swung to a statutory loss on re-measurement and higher operating costs, while adjusted profit tripled as revenue surged 84%.

The Windsor-based firm announced a pretax loss of GBP240 million in 2022, compared to a profit of GBP954 million in 2021. Revenue jumped 84% to GBP33.64 billion from GBP18.30 billion.

The swing to a loss was on re-measurements after taxation, Centrica said, largely reflecting the revaluation of UK energy supply hedging positions due to wholesale gas and power price falls towards the end of the year. The cost for re-measurement and settlement of derivative energy contracts ballooned to GBP8.48 billion in 2022 from GBP434 million in 2021.

However, adjusted operating profit tripled to GBP3.31 billion from GBP948 million on the revenue rise.

Centrica said it intends to extend its existing GBP250 million buyback programme, announced in November, by an additional GBP300 million. This would result in Centrica buying back 10% of its share capital, the power utility said. The company also proposed a full-year dividend of 2.0 pence, compared to none in 2021.

Relx up 3.0% after it posted double-digit rises in full year profit and revenue. The professional information publisher said it plans to spend GBP800 million on share buybacks in 2023.

In 2022, pretax profit rose 18% to GBP2.11 billion from GBP1.80 billion in 2021, while revenue climbed 18% to GBP8.55 billion from GBP7.24 billion.

Looking ahead, Relx said momentum remains strong across the group. It expects underlying growth rates in revenue and adjusted operating profit to remain above historical trends.

Standard Chartered shares rose 3.1%. The bank reported pretax profit of USD4.29 billion in 2022, up from USD3.35 billion in 2021, as interest income jumped by nearly 50% to USD15.25 billion from USD10.25 billion.

The Asia-focused lender said it was optimistic about the reopening of China and for economic growth in Asia in the year ahead.

In the FTSE 250, Indivior plunged 11%. The pharmaceutical firm swung to a pretax loss of USD95 million in 2022 from a profit of USD190 million the previous year.

Indivior explained that it booked a USD290 million exceptional provision in the year as it navigates initial mediation sessions in late January regarding legacy civil multi-district antitrust litigation.

"Because these matters are in various stages, Indivior cannot predict with any certainty how these matters will ultimately be resolved, or the costs, or timing of such resolution. In particular, any final aggregate costs of these matters, whether resolved by settlement or trial, may be materially different from this provision," the company added.

Elsewhere in London, Coca-Cola Europacific Partners shares slipped 0.2%.

The soft-drinks bottling company reported jumps in pretax profit and revenue in 2022 as it declared a record full-year interim dividend of EUR1.68, up 20% against the prior year.

In 2022, pretax profit totalled EUR1.96 billion, up from EUR1.38 billion the year prior. Revenue climbed to EUR17.32 billion from EUR13.76 billion year-on-year.

Looking forward, Coca-Cola EP said it expects comparable revenue growth of between 6% and 8% in 2023.

In European equities on Thursday, the CAC 40 index in Paris was up 1.0%, while the DAX 40 in Frankfurt was up 0.7%.

European Central Bank President Christine Lagarde reiterated Wednesday that the ECB plans to raise its interest rates by half a percentage point.

Data released on Monday showed the 20-nation currency bloc dodged a recession at the end of last year by posting weak-but-positive growth of 0.1%, while inflation has been easing – even if it remains at a high 8.5%.

"In view of the underlying inflation pressures we intend to raise interest rates by another 50 basis points at our next meeting in March," Lagarde told lawmakers at the European Parliament.

The euro stood at USD1.0713 early Thursday, higher against USD1.0669 at the London equities close on Wednesday. Against the yen, the dollar was trading at JPY133.78, lower compared to JPY134.32.

In Tokyo on Thursday, the Nikkei 225 index closed up 0.7%. In China, the Shanghai Composite closed down 1.0%, while the Hang Seng index in Hong Kong closed up 0.8%. The S&P/ASX 200 in Sydney closed up 0.8%.

New York ended higher on Wednesday, with the Dow Jones Industrial Average ending up 0.1%, the S&P 500 up 0.3%, and the Nasdaq Composite up 0.9%.

Brent oil was quoted at USD85.64 a barrel at early in London on Thursday, up from USD84.07 late Wednesday. Gold was quoted at USD1,840.05 an ounce, sharply higher against USD1,832.19.

The International Energy Agency has sharply raised its forecast for global crude oil demand because of the prospect of stronger economic growth in China.

For the whole year, the IEA expects an increase of 2 million barrels per day to an average of 101.9 million barrels per day.

Still to come on Thursday's economic calendar, the US will publish its weekly unemployment claims report at 1330 GMT alongside the producer price index.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
21 Aug 2023 07:23

Indivior settles part of US suboxone litigation

(Sharecast News) - Addiction treatment specialist Indivior announced on Monday that its US subsidiary has entered into an agreement to settle the claims initiated by the end payor class in the ongoing multi-district suboxone antitrust litigation.

Read more
1 Aug 2023 17:39

TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Jul 2023 09:46

LONDON BROKER RATINGS: KBW cuts Aviva 'market perform'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
27 Jul 2023 11:48

Indivior raises 2023 guidance after strong half-year progress

(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting its optimism for the rest of the year.

Read more
27 Jul 2023 10:04

Indivior lifts guidance after strong first half

(Sharecast News) - Pharmaceuticals firm Indivior reported a 24% improvement in net revenue in its half-year report on Thursday, to $529m.

Read more
12 Jun 2023 07:53

LONDON BRIEFING: Shares on the rise; Frasers buys into AO World

(Alliance News) - Stocks in London were set to open higher on Monday, at the start of a busy week of central bank moves.

Read more
5 Jun 2023 07:46

Indivior reaches settlement in litigation with US states

(Sharecast News) - Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully reached an agreement to resolve the claims brought against it by the attorneys general of 41 US states and the District of Columbia.

Read more
2 Jun 2023 18:18

Indivior settles antitrust claims in US regarding Suboxone drug

(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regarding its drug Suboxone.

Read more
25 May 2023 09:23

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
23 May 2023 09:56

Indivior emergency opioid overdose treatment approved by US FDA

(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose.

Read more
23 May 2023 07:48

Indivior's opioid addiction sprat approved by FDA

(Sharecast News) - US health regulators have approved Indivior's Opvee nasal spray treatment for opiod addiction, the company said on Tuesday.

Read more
10 May 2023 17:02

DIRECTOR DEALINGS: Indivior division chief sells GBP1.7 million shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
27 Apr 2023 15:49

UK shareholder meetings calendar - next 7 days

Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
ME Group International PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt Meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
Thursday 4 May 
AIB Group PLCAGM
Aviva PLCAGM
Aviva PLCGM re capital reduction
BAE Systems PLCAGM
Bivictrix Therapeutics PLCAGM
Domino's Pizza Group PLCAGM
Glanbia PLCAGM
Grafton Group PLCAGM
Hammerson PLCAGM
Howden Joinery Group PLCAGM
Hurricane Energy PLCCourt Meeting & GM re takeover by Prax Exploration & Production PLC  
Indivior PLCAGM
IMI PLCAGM
Irish Residential Properties REIT PLCAGM
ITV PLCAGM
Jardine Matheson Holdings LtdAGM
Johnson Service Group PLCAGM
LungLife AI IncAGM
Mincon Group PLCAGM
Mondi PLCAGM
Moneysupermarket.com Group PLCAGM
Morgan Sindall Group PLCAGM
Spirent Communications PLCAGM
Personal Group Holdings PLCAGM
Phoenix Group Holdings PLCAGM
Rathbones Group PLCAGM
SIG PLCAGM
Ten Entertainment Group PLCAGM
Travis Perkins PLCAGM
Witan Investment Trust PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 14:41

Indivior lifts revenue guidance, cuts profit outlook after Opiant deal

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its full-year revenue guidance on Thursday but trimmed its outlook for operating profit due to costs related to the acquisition of Opiant Pharmaceuticals, as it posted a jump in first-quarter profit and revenue.

Read more
27 Apr 2023 13:46

Indivior raises 2023 revenue forecast following Opiant acquisition

(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.